Outcome measures for central nervous system symptoms in myotonic dystrophy type 1: insights from a case-controlled study

被引：0
|
作者：
Hamilton, M. J. [1 ,2 ]
McLean, J. [3 ]
Cumming, S. [2 ]
Ballantyne, B. [1 ]
McGhie, J. [2 ]
Jampana, R. [3 ]
Longman, C. [1 ]
Evans, J. J.
Monckton, D. G. [2 ]
Farrugia, M. E.
机构：
[1] Queen Elizabeth Univ Hosp, West Scotland Clin Genet Serv, Glasgow G51 4TF, Lanark, Scotland
[2] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland
[3] Queen Elizabeth Univ Hosp, Inst Neurol Sci, Dept Neuroradiol, Glasgow G51 4TF, Lanark, Scotland
来源：
NEUROMUSCULAR DISORDERS | 2018年 / 28卷
关键词：
D O I：
10.1016/S0960-8966(18)30321-3
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
D18
引用
收藏
页码：S11 / S11
页数：1
相关论文
共 50 条
  • [41] Heart involvement in type 1 and type 2 myotonic dystrophy. Insights from a 10-year follow-up study
    Fioravanti, F.
    Golzio, P. G.
    Carbone, M. L.
    Panarelli, A.
    Gagliardi, M.
    Mazzilli, S.
    Colopi, M.
    Ferraro, I
    Castagno, D.
    Giustetto, C.
    De Ferrari, G. M.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3145 - 3145
  • [42] The Prevalence and Impact of Symptoms in Childhood and Congenital Onset Myotonic Dystrophy Type-1: A Cross Sectional Study
    Johnson, Nicholas
    Dilek, Nuran
    Ekstrom, Anne-Berit
    Luebbe, Elizabeth
    Hilbert, James
    Eastwood, Eileen
    Moxley, Richard
    Heatwole, Chad
    NEUROLOGY, 2013, 80
  • [43] Polysomnographic findings of myotonic dystrophy type 1/type 2: evidence from case-control studies
    Zhang, Ye
    Ren, Rong
    Yang, Linghui
    Jin, Hui
    Nie, Yuru
    Zhang, Haipeng
    Shi, Yuan
    Sanford, Larry D.
    Vitiello, Michael V.
    Tang, Xiangdong
    SLEEP, 2024, 47 (01)
  • [44] Report of the first Outcome Measures in Myotonic Dystrophy type 1 (OMMYD-1) international workshop Clearwater, Florida, November 30, 2011
    Gagnon, Cynthia
    Meola, Giovanni
    Hebert, Luc J.
    Puymirat, Jack
    Laberge, Luc
    Leone, Mario
    NEUROMUSCULAR DISORDERS, 2013, 23 (12) : 1056 - 1068
  • [45] Characteristics and outcome of immune thrombocytopenia in elderly: Results from a single center case-controlled study
    Michel, Marc
    Rauzy, Odile Beyne
    Thoraval, Francoise Roudot
    Languille, Laetitia
    Khellaf, Mehdi
    Bierling, Philippe
    Godeau, Bertrand
    AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (12) : 980 - 984
  • [46] RESPONSIVENESS OF PERFORMANCE-BASED OUTCOME MEASURES FOR MOBILITY, BALANCE, MUSCLE STRENGTH AND MANUAL DEXTERITY IN ADULTS WITH MYOTONIC DYSTROPHY TYPE 1
    Kierkegaard, Marie
    Petitclerc, Emilie
    Hebert, Luc J.
    Mathie, Jean
    Gagnon, Cynthia
    JOURNAL OF REHABILITATION MEDICINE, 2018, 50 (03) : 269 - 277
  • [47] FEASIBILITY AND EFFECTS OF A PHYSICAL EXERCISE PROGRAMME IN ADULTS WITH MYOTONIC DYSTROPHY TYPE 1: A RANDOMIZED CONTROLLED PILOT STUDY
    Kierkegaard, Marie
    Harms-Ringdahl, Karin
    Edstrom, Lars
    Holmqvist, Lotta Widen
    Tollback, Anna
    JOURNAL OF REHABILITATION MEDICINE, 2011, 43 (08) : 695 - 702
  • [48] Brain MRI abnormalities in the adult form of myotonic dystrophy type 1: A longitudinal case series study
    Conforti, Renata
    de Cristofaro, Mario
    Cristofano, Adriana
    Brogna, Barbara
    Sardaro, Angela
    Tedeschi, Gioacchino
    Cirillo, Sossio
    Di Costanzo, Alfonso
    NEURORADIOLOGY JOURNAL, 2016, 29 (01): : 36 - 45
  • [49] Survival in myotonic dystrophy type 1: a long time follow up-study with special reference to gastrointestinal symptoms
    Ronnblom, Anders
    Ekbom, Anders
    UPSALA JOURNAL OF MEDICAL SCIENCES, 2024, 129
  • [50] MEXILETINE FOR MYOTONIC DYSTROPHY TYPE 1 (DM1): RESULTS FROM A RANDOMIZED, PLACEBO CONTROLLED, CLINICAL EFFICACY TRIAL
    Heatwole, C.
    Luebbe, E.
    Rosero, S.
    Eichinger, K.
    Martens, W.
    Hilbert, J.
    Dekdebrun, J.
    Dilek, N.
    Johnson, N.
    Tawil, R.
    Zareba, W.
    McDermott, M.
    Thornton, C.
    Moxley, R.
    MUSCLE & NERVE, 2018, 58 : S3 - S3
12345